Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.65 |
| ▸ | MAPT | P10636 | 3/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.52 |
| ▸ | HSP90AA1 | P07900 | 3/20 | 0.42 |
| ▸ | HTT | P42858 | 2/20 | 0.42 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.42 |
| ▸ | BLM | P54132 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | EGFR | P00533 | 3/20 | 0.41 |
| ▸ | NPC1 | O15118 | 2/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | GMNN | O75496 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | MMP2 | P08253 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | MMP9 | P14780 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30432091 | 0.81 | EGFR (0.47) | LMNAEGFRTDO2PIK3CDPIK3CA | |
| SCHEMBL27885494 | 0.81 | LMNA (0.96) | LMNAMAPTKDM4ECYP3A4HSP90AA1 | |
| SCHEMBL1096307 | 0.81 | EGFR (0.47) | LMNAEGFRTDO2PIK3CDPIK3CA | |
| SCHEMBL2362178 | 0.79 | LMNA (0.56) | LMNAMAPTKDM4ECYP3A4HSP90AA1 | |
| SCHEMBL6513577 | 0.79 | LMNA (1.00) | LMNAMAPTKDM4ECYP3A4HSP90AA1 | |
| SCHEMBL8313 | 0.79 | LMNA (1.00) | LMNAMAPTKDM4ECYP3A4HSP90AA1 | |
| SCHEMBL9872273 | 0.79 | LMNA (0.65) | LMNAMAPTKDM4ECYP3A4HSP90AA1 | |
| Cyanide SCHEMBL27332417 | 0.78 | LMNA (0.89) | LMNAMAPTKDM4ECYP3A4HSP90AA1 | |
| Cyanide SCHEMBL27465941 | 0.78 | LMNA (0.89) | LMNAMAPTKDM4ECYP3A4HSP90AA1 | |
| Pyrazine SCHEMBL28719971 | 0.78 | LMNA (0.89) | LMNAMAPTKDM4ECYP3A4HSP90AA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 96 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240074310-A1 | LIGHT-EMITTING DEVICE, AND DISPLAY APPARATUS AND ELECTRONIC APPARATUS INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2024-02-29 | — | — | US | claimed |
| CN-117596910-A | Light emitting device, display apparatus including the same, and electronic apparatus | 三星显示有限公司 | 2024-02-23 | — | — | CN | claimed |
| US-20220216419-A1 | LIGHT-EMITTING DEVICE AND ELECTRONIC APPARATUS INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2022-07-07 | — | — | US | claimed |
| EP-2336315-B1 | Enzymatic encoding methods for efficient synthesis of large libraries | NUEVOLUTION AS (DK) | 2017-07-19 | — | — | EP | claimed |
| EP-2336315-A2 | Enzymatic encoding methods for efficient synthesis of large libraries | Nuevolution A/S (DK) | 2011-06-22 | — | — | EP | claimed |
| EP-0944641-B1 | NON-HELICAL SUPRAMOLECULAR NANOSYSTEMS | NANOGEN RECOGNOMICS GMBH (DE) | 2003-07-02 | — | — | EP | claimed |
| EP-0944641-A1 | NON-HELICAL SUPRAMOLECULAR NANOSYSTEMS | Nanogen Recognomics GmbH (DE) | 1999-09-29 | — | — | EP | claimed |
| WO-1998025943-A1 | NON-HELICAL SUPRAMOLECULAR NANOSYSTEMS | AVENTIS RESEARCH & TECHNOLOGIES GMBH & CO KG (DE) | 1998-06-18 | — | — | WO | claimed |
| US-12396364-B2 | Nitrogen-containing organic compound, use thereof, and organic electroluminescent device using same | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2025-08-19 | — | — | US | disclosed |
| US-12396364-B2 | Nitrogen-containing organic compound, use thereof, and organic electroluminescent device using same | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2025-08-19 | — | — | US | disclosed |
| CN-220755379-U | Light emitting device, display apparatus including the same, and electronic apparatus | 三星显示有限公司 | 2024-04-09 | — | — | CN | disclosed |
| US-20240074310-A1 | LIGHT-EMITTING DEVICE, AND DISPLAY APPARATUS AND ELECTRONIC APPARATUS INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2024-02-29 | — | — | US | disclosed |
| CN-117596910-A | Light emitting device, display apparatus including the same, and electronic apparatus | 三星显示有限公司 | 2024-02-23 | — | — | CN | disclosed |
| CN-115894486-B | Hydrogenated pyridoquinazoline compound, composition and application thereof | 北京赛特明强医药科技有限公司 | 2024-02-09 | — | — | CN | disclosed |
| WO-2007062664-A2 | ENZYMATIC ENCODING METHODS FOR EFFICIENT SYNTHESIS OF LARGE LIBRARIES | NUEVOLUTION A/S (DK) | 2007-06-07 | — | — | WO | disclosed |
| US-20060004028-A1 | Novel PARP inhibitor | MOCHIDA PHARMACEUTICAL CO., LTD. (JP) | 2006-01-05 | — | — | US | disclosed |
| EP-1582520-A1 | NOVEL PARP INHIBITORS | MOCHIDA PHARMACEUTICAL CO., LTD. (JP) | 2005-10-05 | — | — | EP | disclosed |
| EP-0944641-B1 | NON-HELICAL SUPRAMOLECULAR NANOSYSTEMS | NANOGEN RECOGNOMICS GMBH (DE) | 2003-07-02 | — | — | EP | disclosed |
| US-4472399-A | Indolo[2',3';3,4]pyrido[2,1-b]quinazoline-5-ones, a process for the preparation thereof, and diuretic compositions and methods using them | CHINOIN GYOGYSZER ES VEGYESZETI TERMEKEK GYARA RT. (HU) | 1984-09-18 | — | — | US | disclosed |
| US-4348396-A | Substituted 11-oxo-11H-pyrido[2,1-b]quinazolines and method of inhibiting allergic reactions with them | HOFFMANN-LA ROCHE INC. (US) | 1982-09-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060004028-A1 | Novel PARP inhibitor | PARP1, PARP2, PARP11 | LMNA 666/4885MAPT 497/4885KDM4E 812/4885 |
| US-12396364-B2 | Nitrogen-containing organic compound, use thereof, and organic electroluminescent device using same | OCIAD2, OCIAD1, NONO | LMNA 3076/4885MAPT 793/4885KDM4E 373/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.